Status:
RECRUITING
Microbiome Testing for the Screening of Colorectal Cancer
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-74 years
Brief Summary
Colorectal cancer (CRC) is one of the most common cancer and cause of cancer death worldwide. Population-based screening programs for average-risk populations have proven effective in reducing both in...
Detailed Description
Colorectal cancer (CRC) is the 3rd most common cancer and the 2nd most common cause of cancer death worldwide, with nearly 2 million new cases and one million deaths in 2020. In the last decades, a po...
Eligibility Criteria
Inclusion
- Patients participating in the national CRC screening program (50-74 years old)
- Positivity to the FIT;
- Ability to provide written informed consent and to be compliant with the study procedures
Exclusion
- Patients unfit for colonoscopy;
- Other oncological conditions;
- Concomitant severe comorbidities or gastrointestinal (GI) organic diseases (e.g. diverticular disease, inflammatory bowel disease);
- Antibiotics,proton pump inhibitors or probiotics within 4 weeks prior to enrollment.
Key Trial Info
Start Date :
November 29 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
1006 Patients enrolled
Trial Details
Trial ID
NCT06588166
Start Date
November 29 2024
End Date
August 30 2026
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Agostino Gemelli, IRCCS
Roma, Italy, 00168